The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback